Casein Kinase Inhibitors

CK1

CK2

Casein Kinase Degraders, Inhibitors & Chemicals

Product Name	CK1	CK2	Purity
Silmitasertib		CK2α, IC₅₀: 1 nM CK2α', IC₅₀: 1 nM	99.94%
IWP-2	CK1δ, IC₅₀: 40 nM		99.93%
Emodin		CK2α Wild-type, IC₅₀: 5.9 μM (at ATP concentration is 50 μM) CK2α Wild-type, IC₅₀: 1.4 μM (at ATP concentration is 10 μM)	99.20%
Ellagic acid		CK2, IC₅₀: 40 nM	99.23%
HDAC/CK2-IN-1		CK2, IC₅₀: 3.67 μM
D4476	CK1, IC₅₀: 0.3 μM		99.94%
PF-670462 dihydrochloride	CKIδ, IC₅₀: 14 nM		99.96%
TBB		CK2, IC₅₀: 0.15 μM (Human CK2)	99.31%
TMX-4116	CK1α		99.76%
Silmitasertib sodium salt		CK2α, IC₅₀: 1 nM CK2α', IC₅₀: 1 nM	99.92%
PF-4800567	CKIδ, IC₅₀: 711 nM		99.69%
BTX-A51	CKIα		98.58%
DMAT		CK2, IC₅₀: 0.13 μM (Human CK2)	98.09%
SR-3029	CKIδ, IC₅₀: 44 nM		99.73%
SGC-CK2-1		CK2α, IC₅₀: 36 nM CK2α', IC₅₀: 16 nM	99.67%
FPFT-2216	CK1α		99.75%
IC261	CKIδ, IC₅₀: 1 μM CkIα1, IC₅₀: 16 μM		99.54%
TAK-715	CK1δ CK1ε		99.76%
AMG-548 dihydrochloride	CK1		99.91%
PF-5006739	CK1δ, IC₅₀: 3.9 nM		99.56%
CKI-7 free base	CK1, IC₅₀: 6 μM CK1, Ki: 8.5 μM		99.80%
BioE-1115		CK2α, IC₅₀: 10 μM	99.56%
TTP 22		CK2, IC₅₀: 100 nM	98.03%
CK2/ERK8-IN-1		CK2, IC₅₀: 0.5 μM CK2, Ki: 0.25 μM	≥99.0%
Hematein		CKII, IC₅₀: 0.74 μM
CK1-IN-1	CKIδ, IC₅₀: 15 nM		99.35%
Casein Kinase inhibitor A86	CKIα		99.26%
TA-01	CKIδ, IC₅₀: 6.8 nM		99.86%
Casein Kinase 2 Substrate Peptide		CK2	98.47%
NCC007	CKIδ, IC₅₀: 3.6 μM CKIα, IC₅₀: 1.8 μM		99.73%
LH846	CKIδ, IC₅₀: 290 nM CKIα, IC₅₀: 2.5 μM		98.04%
Longdaysin	CKIδ, IC₅₀: 8.8 μM CKIα, IC₅₀: 5.6 μM		99.83%
TMX-4113	CK1α		99.08%
MU1742	CKIδ		99.74%
MRT00033659	CKIδ, IC₅₀: 0.9 μM		99.77%
CK2 inhibitor 2		CK2, IC₅₀: 0.66 nM	98.51%
ON 108600		CK2α2, IC₅₀: 0.005 μM CK2α1, IC₅₀: 0.05 μM	99.73%
TBCA		CK2, IC₅₀: 110 nM CK2, Ki: 77 nM	99.45%
PI-828		CK2α2, IC₅₀: 1.127 μM CK2, IC₅₀: 149 nM	99.09%
BRD4/CK2-IN-1		CK2, IC₅₀: 230 nM	98.62%
CK1-IN-2	CKIα, IC₅₀: 123 nM		99.54%
SRPIN803		CK2, IC₅₀: 203 nM	99.17%
A-3 hydrochloride	CK1, Ki: 80 μM	CK2, Ki: 5.1 μM	99.75%
AMG-548	CK1		≥99.0%
(R)-DRF053 dihydrochloride	CK1, IC₅₀: 14 nM		99.30%
LY294002 hydrochloride		CK2α2, IC₅₀: 3.869 μM CK2, IC₅₀: 0.098 μM	99.47%
Quinalizarin		CK2, IC₅₀: 110 nM CK2, Ki: ~50 nM
Casein kinase 1δ-IN-1	CKIδ		99.91%
CK2-IN-3		CK2α, IC₅₀: 1.51 μM CK2α', IC₅₀: 7.64 μM
TID43		CK2, IC₅₀: 0.3 μM
Casein kinase 1δ-IN-3	CKIδ, pIC₅₀: 6.5376 M		99.93%
IQA		CK2
Casein kinase 1δ-IN-4	CK1δ		≥98.0%
Casein kinase 1δ-IN-15	CK1δ, IC₅₀: 0.045 μM
SR-4133	CK1δ, IC₅₀: 10 μM CK1ε, IC₅₀: 58 nM
CK2/PIM1-IN-1		CK2, IC₅₀: 3.787 μM
CK1-IN-3	CK1δ, IC₅₀: 2.22 μM		99.00%
CK1-IN-4	CKIδ, IC₅₀: 2.74 μM
CK2 inhibitor 3		CK2, IC₅₀: 280 nM
Ellagic acid (hydrate)		CK2, IC₅₀: 40 nM CK2, Ki: 20 nM
Casein kinase 1δ-IN-10	CK1δ
Casein kinase 1δ-IN-9	CK1δ		≥98.0%
Emodin (Standard)		CK2α Wild-type
Multi-kinase-IN-6		CK2, IC₅₀: 0.09 μM
TMCB		CK2α, Ki: 83 nM CK2α', Ki: 21 nM
PIM-1/CK2-IN-2		CK2
CKI-7	CK1, IC₅₀: 6 μM CK1, Ki: 8.5 μM
MGD-28	CK1α, DC₅₀: 7.8 nM
Casein Kinase II Receptor Peptide		CK2, Km: 500 μM
SR-1277	CKIδ, IC₅₀: 49 nM
AMG-548 hydrochloride	CK1
EGFR-IN-57		CK2α, IC₅₀: 0.171 μM
4,5,6,7-Tetrabromo-1H-benzimidazole		CK2
Casein kinase 1δ-IN-5	CK1δ, IC₅₀: 47 nM
CK2-IN-12		CK2, IC₅₀: 0.8 μM
CSNK2-IN-2		CK2

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4